The Charles Schwab Corporation (SCHW) vs United Therapeutics Corporation (UTHR)
UTHR leads on 8 of 15 compared metrics, though SCHW is the cheaper stock.
A side-by-side comparison of The Charles Schwab Corporation and United Therapeutics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
SCHW
The Charles Schwab Corporation
$91.10Financial Services
UTHR
United Therapeutics Corporation
$545.96Healthcare
Not enough overlapping price history to compare SCHW and UTHR.
SCHW vs UTHR: by the numbers
- •SCHW is the larger company ($158.44B vs $23.17B market cap).
- •SCHW trades at the lower earnings multiple (18.08 vs 20.18 P/E).
- •UTHR converts more revenue to profit (40.61% vs 33.26% net margin).
- •UTHR grew revenue faster over the past five years (16.05% vs 14.85% CAGR).
- •SCHW pays a dividend (1.30% yield) while UTHR does not currently pay one.
Which is better, SCHW or UTHR?
Metric tally: SCHW 7 · UTHR 8It depends on what you're optimizing for:
ValueSCHW(lower P/E)
GrowthUTHR(faster 5Y revenue CAGR)
QualityUTHR(higher ROIC)
Valuation
| Metric | SCHW | UTHR |
|---|---|---|
| P/E ratio | 18.08● | 20.18 |
| Forward P/E | 12.44● | 16.48 |
| P/S ratio | 5.63● | 8.13 |
| P/B ratio | 3.24● | 4.37 |
| PEG ratio | 0.36● | 1.16 |
| EV / EBITDA | 10.90● | 14.41 |
| FCF yield | 6.09%● | 3.95% |
Profitability
| Metric | SCHW | UTHR |
|---|---|---|
| Gross margin | 87.57% | 86.58% |
| Operating margin | 43.04% | 45.34%● |
| Net margin | 33.26% | 40.61%● |
| ROE | 19.14% | 21.82%● |
| ROIC | 9.50% | 16.14%● |
Dividends
| Metric | SCHW | UTHR |
|---|---|---|
| Dividend yield | 1.30% | — |
| Payout ratio | 25.21% | — |
Growth (annualized)
| Metric | SCHW | UTHR |
|---|---|---|
| Revenue CAGR (5Y) | 14.85% | 16.05%● |
| EPS CAGR (5Y) | 17.05% | 20.93%● |
| FCF CAGR (5Y) | 8.89% | 12.12%● |
| Total return CAGR (5Y) | 5.66% | 24.96%● |
Frequently asked
- Which is better, SCHW or UTHR?
- It depends on your goal. value: SCHW (lower P/E); growth: UTHR (faster 5Y revenue CAGR); quality: UTHR (higher ROIC). Across all compared metrics, UTHR leads 8 to 7.
- Is SCHW or UTHR cheaper?
- On trailing earnings, SCHW is cheaper: SCHW trades at a 18.08 P/E and UTHR at 20.18.
- Which has grown faster, SCHW or UTHR?
- Over the past five years, UTHR grew revenue faster — SCHW at a 14.85% CAGR versus UTHR at 16.05%.
- Does SCHW or UTHR pay a bigger dividend?
- SCHW pays a dividend (1.30% yield) while UTHR does not currently pay one.
- Is SCHW or UTHR more profitable?
- UTHR runs the higher net margin — SCHW at 33.26% versus UTHR at 40.61%.
- Which has been the better investment, SCHW or UTHR?
- Over the past 10-year, UTHR delivered the higher annualized total return — SCHW at 13.78% versus UTHR at 17.22%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Charles Schwab P/E ratioUnited Therapeutics P/E ratioCharles Schwab dividend yieldUnited Therapeutics dividend yieldCharles Schwab ROEUnited Therapeutics ROECharles Schwab operating marginUnited Therapeutics operating marginCharles Schwab revenue growthUnited Therapeutics revenue growthCharles Schwab free cash flowUnited Therapeutics free cash flow
Charles Schwab & United Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.